Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

MRP1 overexpression determines poor prognosis in prospectively treated patients with localized high-risk soft tissue sarcoma of limbs and trunk wall: an ISG/GEIS study.

Martin-Broto J, Gutierrez AM, Ramos RF, Lopez-Guerrero JA, Ferrari S, Stacchiotti S, Picci P, Calabuig S, Collini P, Gambarotti M, Bague S, Dei Tos AP, Palassini E, Luna P, Cruz J, Cubedo R, Martinez-Trufero J, Poveda A, Casali PG, Fernandez-Serra A, Lopez-Pousa A, Gronchi A.

Mol Cancer Ther. 2014 Jan;13(1):249-59. doi: 10.1158/1535-7163.MCT-13-0406. Epub 2013 Oct 21.

2.
4.

Prognostic impact of multidrug resistance gene expression on the management of breast cancer in the context of adjuvant therapy based on a series of 171 patients.

Moureau-Zabotto L, Ricci S, Lefranc JP, Coulet F, Genestie C, Antoine M, Uzan S, Lotz JP, Touboul E, Lacave R.

Br J Cancer. 2006 Feb 27;94(4):473-80.

5.

Expression of multidrug resistance-associated proteins in paediatric soft tissue sarcomas before and after chemotherapy.

Citti A, Boldrini R, Inserra A, Alisi A, Pessolano R, Mastronuzzi A, Zin A, De Sio L, Rosolen A, Locatelli F, Fruci D.

Int J Oncol. 2012 Jul;41(1):117-24. doi: 10.3892/ijo.2012.1433. Epub 2012 Apr 10.

PMID:
22504834
6.

Quality of surgery and neoadjuvant combined therapy in the ISG-GEIS trial on soft tissue sarcomas of limbs and trunk wall.

Gronchi A, Verderio P, De Paoli A, Ferraro A, Tendero O, Majò J, Martin J, Comandone A, Grignani G, Pizzamiglio S, Quagliuolo V, Picci P, Frustaci S, Dei Tos AP, Palassini E, Stacchiotti S, Ferrari S, Fiore M, Casali PG.

Ann Oncol. 2013 Mar;24(3):817-23. doi: 10.1093/annonc/mds501. Epub 2012 Oct 30.

7.

[Expression of MDR1 and GST-pi in osteosarcoma and soft tissue sarcoma and their correlation with chemotherapy resistance].

Wei L, Song XR, Wang XW, Li M, Z uo WS.

Zhonghua Zhong Liu Za Zhi. 2006 Jun;28(6):445-8. Chinese.

PMID:
17152492
8.

Treating soft tissue sarcomas with adjuvant chemotherapy.

Patrikidou A, Domont J, Cioffi A, Le Cesne A.

Curr Treat Options Oncol. 2011 Mar;12(1):21-31. doi: 10.1007/s11864-011-0145-5. Review.

PMID:
21384115
9.

Expression of multidrug resistance proteins, P-gp, MRP1 and LRP, in soft tissue sarcomas analysed according to their histological type and grade.

Komdeur R, Plaat BE, van der Graaf WT, Hoekstra HJ, Hollema H, van den Berg E, Zwart N, Scheper RJ, Molenaar WM.

Eur J Cancer. 2003 May;39(7):909-16.

PMID:
12706359
10.

Multidrug resistance proteins in primary and metastatic soft-tissue sarcomas: down-regulation of P-glycoprotein during metastatic progression.

Komdeur R, Molenaar WM, Zwart N, Hoekstra HJ, van den Berg E, van der Graaf WT.

Anticancer Res. 2004 Jan-Feb;24(1):291-5.

11.

Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: a study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931.

Kasper B, Ouali M, van Glabbeke M, Blay JY, Bramwell VH, Woll PJ, Hohenberger P, Schöffski P.

Eur J Cancer. 2013 Jan;49(2):449-56. doi: 10.1016/j.ejca.2012.08.007. Epub 2012 Sep 10.

PMID:
22975215
12.

Neoadjuvant chemoradiotherapy for patients with high-risk extremity and truncal sarcomas: a 10-year single institution retrospective study.

Look Hong NJ, Hornicek FJ, Harmon DC, Choy E, Chen YL, Yoon SS, Nielsen GP, Szymonifka J, Yeap BY, DeLaney TF, Mullen JT.

Eur J Cancer. 2013 Mar;49(4):875-83. doi: 10.1016/j.ejca.2012.10.002. Epub 2012 Oct 22.

13.

Incidence of P-glycoprotein overexpression and multidrug resistance (MDR) reversal in adult soft tissue sarcoma.

Coley HM, Verrill MW, Gregson SE, Odell DE, Fisher C, Judson IR.

Eur J Cancer. 2000 May;36(7):881-8.

PMID:
10785593
14.

Evaluation of P-glycoprotein expression in soft tissue sarcomas of the extremities.

Serra M, Scotlandi K, Manara MC, Maurici D, Benini S, Sarti M, Nini G, Barbanti-Brodano G, Baldini N.

Cytotechnology. 1996;19(3):253-6.

PMID:
8862015
15.

Role of ABCB1 and ABCC1 gene induction on survival in locally advanced breast cancer.

Atalay C, Demirkazik A, Gunduz U.

J Chemother. 2008 Dec;20(6):734-9.

PMID:
19129072
16.

Breast cancer resistance protein expression is associated with early recurrence and decreased survival in resectable pancreatic cancer patients.

Lee SH, Kim H, Hwang JH, Lee HS, Cho JY, Yoon YS, Han HS.

Pathol Int. 2012 Mar;62(3):167-75. doi: 10.1111/j.1440-1827.2011.02772.x. Epub 2012 Feb 6.

PMID:
22360504
17.

Evaluation of newer prognostic markers for adult soft tissue sarcomas.

Levine EA, Holzmayer T, Bacus S, Mechetner E, Mera R, Bolliger C, Roninson IB, Das Gupta TK.

J Clin Oncol. 1997 Oct;15(10):3249-57.

PMID:
9336362
18.

Significance of MDR1, MRP1, GSTpi and GSTmu mRNA expression in acute lymphoblastic leukemia in Indian patients.

Gurbuxani S, Singh Arya L, Raina V, Sazawal S, Khattar A, Magrath I, Marie J, Bhargava M.

Cancer Lett. 2001 Jun 10;167(1):73-83.

PMID:
11323101
19.
20.

Survival in primary soft tissue sarcoma of the extremities and trunk.

Peiper M, Zurakowski D, Zornig C.

Langenbecks Arch Chir. 1997;382(4):203-8.

PMID:
9396000
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk